Auriga Laboratories, Inc. Files Advanced Drug-Delivery Patent Application To Significantly Expand Revenues From Proprietary Drug Brands; Platform Technology Strengthens Company’s Strategy To Extend Brand Exclusivity In Multibillion-Dollar Pharmaceutical M

NORCROSS, Ga.--(BUSINESS WIRE)--Sept. 15, 2006--Auriga Laboratories, Inc. (OTCBB:ARGA), a specialty pharmaceutical company driving high-growth revenues through acquisition of valuable brand portfolios and innovative drug development programs, today announced the filing of a new provisional patent application for a key platform technology that will provide market exclusivity of its proven pharmaceutical brands.